Fourteen goats were experimentally infected with Trypanosornu brucei with the following results: Four animals became terminally ill 24 to 47 days after inoculation of trypanosomes and were killed for necropsy. A second group of four goats became sick, had signs of systemic trypanosomiasis. were treated with diminazine aceturate (Berenil) and recovered showing no signs of disease over observation periods of 15 1 to 163 days. A third group of six goats, were treated with Berenil and temporarily recovered and in 60 to 79 days after therapy: four of these goats underwent relapse infection characterized by severe central nervous system (CNS) disease. Two of these goats were necropsied 45 days after chemotherapy, before clinical signs were evident, to show early neurological lesions. In group 3 (the relapse group), the microscopic changes became more severe as relapse infection progressed. Microscopically, the central nervous system lesions were edema, hyperemia. and infiltration of plasma cells, small lymphocytes, and some macrophages in the leptomeninges, choroid plexus. and brain parenchyma. Relapse infection is discussed from the standpoint of an occult phase of the disease where parasites are protected from the effects of trypanocidal drugs by the blood-brain barrier.
Central nervous system involvement in animal trypanosomiasis caused by the Trvpanosoina britcei subgroup parasites is reported infrequently in the literature. In a review of the pathology of animal trypanosomiases, chronic central nervous system lesions in T. brucei-infected cattle, goats, sheep, monkeys, and rodents were de~cribed.~' The central nervous system histology has also been reported in the COW,^^^.^^^^^ rat,h6 laboratory mouse,7.53.63.64 deer mouse,61 field dog,37 and m~n k e y .~,~~ Ruminants, such as cattle and goats, are among the most important animals in Africa from an economic standpoint, but they seldom have nervous system involvement in trypanos o r n i a s i~.~.~~ This is because the nervous system is affected late in the chronic disease and unthrifty animals are slaughtered before long standing infections can become e~t a b l i s h e d .~~ Also, T. brucei infection is more difficult to diagnose in cattle than the more acute infections caused by T. congolense and T. vivax. s ' Neurological involvement may be important because the trypanocides which are commonly used in animals, e.g., Berenil (diminazine aceturate, Farbwerke, AG, Frankfurt, W. Germany), cannot cross the blood-brain bamer4i.6s and therefore cannot be expected to cure late stage T. brucei infection with neurological i n v~l v e m e n t .~~ Perhaps more important than primary neurological disease in T. brucei infection is relapsing infection in animals after treatment with trypanocidal drugs for control of the systemic disease. These drugs effectively eliminate the parasites in the bloodstream and the animal appears to fully recover, but later many undergo a relapse characterized by severe neurological infection.
The relapsing form of the disease has been reported in cattle experimentally infected with T. vivasand subsequently treated with Berenil.I4 These animals relapsed with neurological disease in ten to 25 days after therapy. Following drug therapy, trypanosomes were absent from the bloodstream as determined by inoculation of blood into susceptible rodents. The trypanosomes recovered from the brain were still susceptible to the effects of the drug, indicating that the relapse was not due to drug resistance. In another report," cattle were infected with two different drug resistant strains of T. congolense and T. viva.\-, respectively, and the animals relapsed 2 to 6 weeks after therapy. Relapsing infections were observed in cattle after 2 to 4 weeks of treatment with Berenil.'* A case of relapsing neurological disease after Berenil therapy was also reported in a cow experimentally infected with T. brircei.
Experimentation on relapsing infection after chemotherapy has been done in rodents. With Berenil therapy, complete cures were obtained early in T. bruceiinfected mice, but after 21 days the therapy failed to prevent relapsing infection and the mice died with severe neurological disease." 24 Following treatment. try-panosomes disappeared from the circulation. but later. the parasites re-established themselves. These relapse infections were attributed to the presence of trypanosomes in the brain, where they were unaffected by the effects of drugs which were unable to cross the bloodbrain barrier." Poltera et al.52 conducted experiments in mice. similar to those above, and indicated that melarsoprol was curative in the late stages of infection if given in high enough doses.52 Results in mice infected with T. gurnbiense were similar.62.6' After treatment with different drug regimes the parasitemias disappeared, but later the mice had relapsing central nervous infections.
The present experiment was done to determine if goats, one ofthe ruminant hosts that becomes naturally infected with trypanosomiasis. would develop relapse infection of the central nervous system after experimental infection with T. hrzrcei and treatment with Berenil. In this report the pathological changes in the brain are described. In a previous report,67 the clinicopathological data are presented.
Materials and Methods
The 14 goats used in this study were indigenous East African X Galla goats purchased from an area in Kenya free of trypanosomiasis. These animals were selected randomly for the experimental groups. Only male castrates of approximately 12 months of age were used to maintain uniformity. They were housed in an insect-free isolation unit and allowed free access to feed and water. The goats were inoculated with T. brucei ILRAD 1797, a cloned serodeme (gene line) previously de~cribed.~' Each goat was injected intravenously with ten bloodstream forms of the organism.
To allow time for the systemic infection to become well established and for the parasites to invade the central nervous system, the disease was allowed to progress until day 46 when, in advanced stages of infection. the goats were treated with Berenil. Four goats were killed for necropsy examination before drug treatment. The drug was given as a single injection intramuscularly and the dosage was 10 mp'kg of body weight. The untreated goats were sacrificed 24 to 47 days after inoculation; the treated animals were sacrificed 9 1 to 163 days after inoculation.
The animal groupings, treatments, numbers in each group. and lengths of experimental periods are shown in Table 1 . Briefly, group 1 consisted of four goats which were inoculated with T. brucei but not treated with Berenil. These goats were necropsied at 24 to 47 days after inoculation with tr).panosomes. Group 2 included four goats which were injected with parasites, later treated with Berenil, and fully recovered. Two of these were necropsied at 15 1 and two at 163 days after inoculation with trypanosomes. Group 3 was comprised of six goats which were inoculated with the parasite. These goats had advanced signs of systemic infection. were treated with Berenil, and had neurological manifestations after 60 to 79 days. They were necropsied at various periods from 45 to 1 16 days after therapy.
Throughout the experiment. parasite populations were isolated and tested for drug sensitivity, and the central nervous system was examined at necropsy for the presence of tryp a n o~o m e s .~~ For detection of parasitemia during the course of infection.
the following methods were employed. Jugular blood samples in disodium ethylenediaminetetraacetate from each goat were collected daily for the first 3 weeks and thereafter twice per week. The packed cell volume (PCV) was measured after centrifugation in a microhematocrit centrifuge (Drummond Scientific Co.. Broomhall, PA), and the blood was examined for trypanosomes by the blood buEy coat phase contrast technique.J2 Following chemotherapy, the goats were bled daily for 1 week to confirm the elimination of blood parasitemia. after which twice weekly examinations were resumed. These results have been rep~rted.~' To confirm the successful elimination of parasites from the circulation after chemotherapy, 0.2 ml blood from each goat was inoculated into each of five mice on day 12 after treatment. The mice were then monitored for 30 days for para~itemia.~' Prior to euthanasia by intravenous injection of 15 ml of pentobarbitone sodium (Euthatol. May and Baker Ltd.. Dagenham. England). blood was drawn from the jugular vein and cerebrospinal fluid and from the cisterna magna for tests as r e p~r t e d .~' At necropsy, samples of cerebral cortex, basal ganglia. pons. medulla (obex level), cerebellum. spinal cord ( C l . T6, L1. SI), and choroid plexus (lateral and fourth ventricles) were placed in 3% mercuric chloride formalin for histology. Tissues were embedded in paraffin, sectioned at 4 to 6 microns, and stained with hematoxylin and eosin (HE). Selected tissues were also stained with lux01 fast blue and methyl green-pyronine.
Results
Three goats from group 1 and three goats from group 3 had clinical signs of central nervous system involvement (Table 1 ). These animals had difficulty in standing and had to brace themselves against the wall of the stall. Some goats demonstrated "sawhorse" posture with fore and hind limbs extended. Others could walk, but had weakness in the hind legs and had wobbly gait. Some were depressed and had periodic somnolence and stood with a drooped head. Others were recumbent and had torticollis, paddling, or chewing movements. Periodic muscle twitching, head tremor, and hyperexcitability were also observed.
Goats with macroscopic central nervous system lesions are indicated in Table 1 . In group 1 goats, the brain was yellowish in color, and mild meningeal hyperemia was noticeable, especially over the basilar parts of the brain. One goat had ecchymotic hemorrhages in the brain parenchyma and walls of the lateral ventricles. No gross changes of the central nervous system were present in the group 2 goats.
Four group 3 goats had gross changes similar to those in group 1. These changes were mild in one goat and severe in three others (Table 1) . With severe lesions, the meningeal surfaces appeared pale and semi-opaque, and the brain was slightly yellowish in color and less dense, as though edematous. Group 1 goats had mild to moderately severe microscopic lesions which consisted of hyperemia and edema of the leptomeninges, and small numbers of plasma cells and lymphocytes in the subarachnoid space (Table 1) . Plasma cells formed cuffs around the blood vessels that course through the subarachnoid space and entered the outer brain parenchyma. The most severe lesions involved the cerebral cortex, cerebellum, and pons. In the choroid plexi of the lateral and fourth ventricles the fenestrated capillaries were hyperemic, and the plexus stroma was edematous and contained perivascular and focal collections of plasma cells and lymphocytes. Plasma cells outnumbered lymphocytes by a ratio of 10 : 1. In lesions of medium severity, plasma cells in large numbers were present in the plexus stroma. Occasionally, extravascular trypanosomes and macrophages with phagocytosed hemosiderin were also found. There were no microscopic changes in the group 2 goats.
In group 3, three goats had mild central nervous system lesions similar to those described above; two of these had lesions of the choroid plexus but no lesions of the meninges and one had meningeal lesions only. The remaining three goats in this group had advanced meningeal lesions that involved particularly the brainstem, basilar cerebrum, cerebellum, and to a lesser extent, the cervical spinal cord. The sulci and fissures of the cerebral hemispheres were involved to the greatest extent. Widespread plasma cell infiltration caused expansion of the subarachnoid space ( Fig. 1 ). These cells extended via the Virchow-Robin spaces into the superficial brain parenchyma (Fig. 2 ). The neuropil directly below the affected pia mater was edematous. Perivascular cuffs of plasma cells were seen in deeper areas of the gray and white matter, particularly in the cerebral hemispheres and basal ganglia.
The lesions in the choroid plexus varied in severity in the different plexuses; the plexuses of the lateral ventricles were most severely affected. The least severe lesions consisted of hyperemia, edema, and a few plasma cells and lymphocytes which appeared in small foci or around stromal capillaries (Fig. 3) . Lesions of moderate seventy consisted of more edema and larger accumulations of plasma cells and lymphocytes. In the most severe lesions, the plexus stroma was diffusely infiltrated with plasma cells and the villi were greatly distended. Clusters of trypomastigotes (flagellated trypanosomes) were present in the plexus interstitium, sometimes in association with focal infiltrates of polymorphonuclear neutrophils (Fig. 4) . The ependymal cells covering these villi were swollen and had hydropic degeneration and were slightly separated from one another (Fig. 5 ) . The cerebrospinal fluid contained acidophilic amorphous debris, and a few plasma cells and lymphocytes. The ependymal cell layer that lines the brain ventricles was unaffected.
Discussion
Central nervous system lesions were found in the goats in this study, particularly in the group that relapsed after chemotherapy. The most prominent changes were in the leptomeninges and choroid plexus.
Leptomeningitis occurred over the convexities of the cerebral hemispheres and cerebellum and base of the brain. The most severe changes were found in the sulci of the cerebral hemispheres. The inflammatory exudate consisted mainly of plasma cells and to a lesser extent small lymphocytes and macrophages. A few clusters of trypomastigotes were seen in the subarachnoid space. An identical inflammatory infiltrate that consisted primarily of mononuclear cells, formed perivascular cuffs around blood vessels in the Virchow-Robin spaces.
The lesions in the choroid plexus had sequential development. The earliest changes were hyperemia, edema, and accumulations of small numbers of plasma cells and lymphocytes in the plexus stroma. often around blood vessels. As the lesions became more se-vere, the edema and the increased numbers of plasma cells caused wide expansion of the plexus. In the most advanced stage the plexus was diffusely infiltrated with plasma cells, and to a lesser extent lymphocytes. In areas where trypomastigotes were clustered, polymorphonuclear neutrophils were found. The ependymal cells covering the choroid villi of thickened plexuses had hydropic degeneration and the cells were separated from one another as though the tight intercellular junctions had opened. This change was only seen in the most advanced cases. The central nervous system changes in the goats were similar to those reported in other animal^-'^.^^.^' and man7.35.39-4n.s4 with chronic trypanosomiasis caused by the T. brucei subgroup of organisms.
The significance of the choroid plexus change is difficult to assess.s3 Many workers feel that the choroid plexus may be the site where trypanosomes transfer across the blood-brain Large numbers of trypomastigote forms are frequently found in the choroid plexus stroma, especially with relapse infection after C~emO~~eraPY,7.47.49.50,S3,S~.6 I even the amastigote form has been reported in this site.48 Many workers now believe that these parasites pass into the plexus stroma through the fenestrated capillaries, and reside there for an undetermined period of time prior to transfer across the blood-brain barrier ofthe choroid plexus.'-) During the period when the parasites are present in choroid plexus blood vessels or interstitium they are susceptible to the effects of trypanocidal drugs, but when they transfer across the blood-brain bamer the drugs can not follow-at least in sufficient concentration to affect the parasites. 17.1821. 33 The ependymal cells that line the ventricles of the brain lack tight junctions, thus do not constitute part of the blood-brain bamer, so there is no anatomical bamer to prevent passage of parasites from the cerebrospinal fluid to the brain parenchyma. A similar pattern of pathogenesis may exist in the passage of the parasites through the blood-brain barriers constituted by the basement membranes and tight junctions between the capillary endothelial cells in the leptomeninges and brain parenchyma, and by the tight junctions that connect the arachnoidal cells. 55 Once the blood-brain bamer is traversed the trypanosomes multiply rapidly and overwhelm the host with little time for immunological response. l 6
In sequential studies in laboratory mice with T. brucei infection, it has been observed that trypomastigotes accumulate in the choroid plexus stroma after the fourth week of infecti~n.~) By electron microscopy, trypomastigotes as well as electron dense deposits suggestive of immune complexes were present in the subendothelial and subependymal areas of the plexus stroma. The rise in C l q binding activity with decrease in levels of C3 was suggestive of formation of immune complexes in the circulation of these mice. Immune complexes have been found by other workers in chronic t~y p a n o s o m i a s i s ;~~~~~~~.~~ they represent an expression of polyclonal B cell activity that is highly characteristic of this disease.18 Autoantibodies may also be involved in the formation of immune c o m p l e x e~.~~. '~.~~ Immune complex deposition in the choroid plexus stroma with a local immune process may be responsible for opening of the tight junctions of the ependymal cells-allowing the trypanosomes to cross the blood-brain bamer.8,'0,'5.19.'9.51. 
Autoantibodies may also be involved in immune complex
There is little possibility that parasites cross the blood-brain bamer by passing through the cytoplasm of choroid ependymal cell^.^^.^^ This route exists for the passage of proteins but not for entire organisms such as trypanosomes.
Opening of the tight junctions could also occur from release of toxic factors from the trypanosomes," but it is difficult to assess since toxin production has never been clearly demonstrated in this disease. Ependymal The goats with advanced disease in this study had lymphocytes and plasma cells in the cerebrospinal fluid. It is intriguing to speculate on how plasma cells reach the cerebrospinal fluid. One possibility is that these immobile cells are derived from immunologically committed small B lymphocytes which traverse the blood-brain barrier and differentiate into plasma cells.
A few macrophage type cells were also seen in the cerebrospinal fluid. These cells are probably recruited as blood monocytesg which cross the blood-brain barrier late in disease after ependymal injury. 
